Dashboard
- All
-
Following
You must log in
before getting
tailored content. -
Interests
You must log in
before getting
tailored content. - Most liked
- Most viewed
Chiara Recchi
Senior Research AssociateDirectory:
Expertise:
Chiara Recchi graduated cum laude in Italy with a Master in the laboratory of Cesare Montecucco at the University of Padova. She then moved to France at the Pasteur Institute in the group of Brigitte Gicquel, where she obtained her PhD in Microbiology for her work on the virulence factors of Mycobacterium tuberculosis.
Later, she extended her interest to cell biology and she trained as a postdoc in the laboratory of Philippe Chavrier at the Curie Institute in Paris. Here she became involved in the study of intracellular trafficking and how this controls the metastatic properties of cancer cells.
She thus continued working in this field when in 2007 she moved to London, where she became research associate at the Imperial College in Miguel Seabra’s group. Here she developed her own project combining her expertise in intracellular trafficking with the lab’s experience in Rab proteins. This led to one of the first descriptions of Rab27a as key to tumour progression.
She now leads the Tumour Suppressor Group at the Ovarian Cancer Action Research Centre, directed by Hani Gabra, at Imperial College London.
Her main focus is to understand how the tumour suppressor protein OPCML controls trafficking and signalling of Receptor Tyrosine Kinases in ovarian cancer.
view this profile
Directory:
Tags:
|
Keen to discover the effectiveness of short healthcare videos as a communication tool for patients, Dr. Seth Rankin, the managing partner of Wandsworth Medical Centre, London, emailed his patients living with diabetes short videos about their condition, and surveyed their opinions afterwards, which we report.
The clinicians "Healthcare information in video format distributed directly to patients' mobiles is a more effective way to educate people living with diabetes, and propel them towards self management with an eye to slowing the onset of complications," says Rankin. According to Dr. Sufyan Hussain,an endocrinologist and lecturer from Imperial College, London, Clinical Lead on the Wandsworth project, "Despite accounting for 10% of the NHS budget and 8% of UK's population diabetes healthcare systems still need considerable improvement, particularly in management, strategy and infrastructure. Communicating important health information via video, can help significantly to improve the quality of care and efficiency in an over burdened healthcare system." |
|
|
|
BritPACT
British Psoriatic Arthritis ConsortiumThe British Psoriatic Arthritis ConsorTium has been created to bring together people with an interest in psoriatic arthritis.
its mission is to facilitate and advance research and best practice in psoriatic arthritis in the United Kingdom.
Its main goals are:
- To bring together UK individuals with an interest in PsA
- To create a UK infrastructure to undertake studies in PsA
- To collaborate in studies improving knowledge and outcome in PsA
- To develop and execute research ideas in PsA
- To engage with ARUK clinical study group to facilitate research in PsA
- To engage with the Translational Research Partnerships in PsA
- To collaborate with BRIT-SPA
- To collaborate with GRAPPA
- To engage with relevant dermatology stakeholders
- To develop and disseminate knowledge around PsA and comorbidities
- To ensure patient and public involvement at all levels
view this profile
Axel Walther
Consultant Medical OncologistDr Axel Walther is a medical oncologist and Director for Research in Oncology at University Hospitals Bristol. He is the co-lead for the Cancer Research Theme at the University of Bristol.
He completed his undergraduate degree at Cambridge University followed by Medical School at Oxford University. He trained at the Hammersmith, Middlesex and Royal Marsden Hospitals and obtained his PhD from University College London.
His research interests are genetic markers of cancer risk and outcome, and he has collaborated in the discovery of several low-penetrance colon cancer susceptibility loci, thought to make up part of the inherited risk of colon cancer. Dr Walther has presented these findings at global conferences, published in and reviewed articles for high-impact journals and contributed to textbooks on cancer.
view this profile
Directory:
Tags:
|
|
Directory:
Tags:
|
|
Directory:
Tags:
|
|
